Researchers from the Walter and Eliza Hall Institute of Medical Research in Melbourne have developed a new drug that is claimed to have the capability to completely kill cancer cells or put them to sleep in order to they do not interfere with the good once and also reflect no side effects.
The researchers say that their new drug can pave way to amazing possibilities for cancer patients and their tests have also showcased substantial promise in stopping cancer progressions in models of liver and blood cancers as well as in order to delay cancer relapse. The new drug is among the first ones to specifically target particular proteins KAT6A and KAT6B, both of whom are proven in augmenting cancer. Currently, KAT6A is rated within the top dozen of genes that are commonly amplified during cancer.
As far as animal models are concerned, the tests have shown that depletion of KAT6A can multiply four time the life expectancy in case of blood cancer called lymphoma. Now with this information in hand, the researchers aspired to formulate drug that can treat cancer and their new compound has shown substantial promise during the preclinical testing. The compound has shown its potency against tumor cells while not disturbing the healthy cells at the same time.
What makes this study a unique and a highly promising one is that they do not cause any potential DNA damage, as is the case with radiotherapy and chemotherapy. The drug merely makes the cancer cells to sleep indefinitely!